- The World Health Organization is recommending against doctors using Gilead Sciences' (NASDAQ:GILD) remdesivir (Veklury) to treat hospitalized COVID-19 patients.
- Gilead shares are down 1.6% after hours.
- “There is currently no evidence that it improves survival or the need for ventilation,” a
WHO recommends doctors not use remdesivir to treat COVID-19; GILD -1.6%
Recommended For You
About GILD Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| GILD | - | - |
| Gilead Sciences, Inc. | ||